Defects in translation-dependent quality control pathways lead to convergent molecular and neurodevelopmental pathology.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33899734.
- Also identified by DOI 10.7554/eLife.66904 and PMC identifier 8075583.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Translation-dependent quality control pathways such as no-go decay (NGD), non-stop decay (NSD), and nonsense-mediated decay (NMD) govern protein synthesis and proteostasis by resolving non-translating ribosomes and preventing the production of potentially toxic peptides derived from faulty and aberrant mRNAs. However, how translation is altered and the in vivo defects that arise in the absence of these pathways are poorly understood. Here, we show that the NGD/NSD factors <i>Pelo</i> and <i>Hbs1l</i> are critical in mice for cerebellar neurogenesis but expendable for survival of these neurons after development. Analysis of mutant mouse embryonic fibroblasts revealed translational pauses, alteration of signaling pathways, and translational reprogramming. Similar effects on signaling pathways, including mTOR activation, the translatome and mouse cerebellar development were observed upon deletion of the NMD factor <i>Upf2</i>. Our data reveal that these quality control pathways that function to mitigate errors at distinct steps in translation can evoke similar cellular responses.
Medical subject headings
- Cell Cycle Proteins
- Cerebellum
- Endonucleases
- GTP-Binding Proteins
- Neurogenesis
- Neurons
- Peptide Chain Termination, Translational